SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES IN SINGLE REACTOR Russian patent published in 2001 - IPC

Abstract RU 2167875 C2

FIELD: organic chemistry, chemical technology. SUBSTANCE: invention proposes the improved method of synthesis of (S)-4-{[3-[2-(dimethylamino)-ethyl]-1H-indole-5-yl]-methyl}-2-oxa-zolindinone that involves the following stages: (a) formation of carbamate of the formula (III) from methyl-4-nitro-(L)-phenylalaninate hydrochloride; (b) reduction of compound of the formula (III) to yield methyl-(S)-N-butoxy-carbonyl-4-aminophenylalaninate of the formula (IV) ; (c) reduction of ester methyl group in compound of the formula (IV) to yield (S)-N-butoxycarbonyl-4-aminophenylalanilol of the formula (V) ; (d) ring closure in compound of the formula (V) to yield (S)-4-aminobenzyl-2-oxazolidinone hydrochloride of the formula (VII) ; (e) formation of diazonium salt from compound of the formula (VI) and the following reduction and yielding (S)-4-(4-hydrazinobenzyl)-2-oxazolidinone hydrochloride hydrazine of the formula (VII); f) Fischer's reaction of compound of the formula (VII) to yield (S)-4-{[3-[2-(dimethylamino)-ethyl] -1H-indole-5-yl] -methyl} -2-oxazolidinone. The end compound is agonist of 5-HT1-like receptors that are used effectively for treatment of patients suffering with migraine. EFFECT: improved method of synthesis, increased yield and purity of end product, simplified technology. 25 cl, 4 ex

Similar patents RU2167875C2

Title Year Author Number
INDOLE DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS AND SOLVATES THEREOF, METHODS OF PREPARING THEREOF, DRUG FOR TREATMENT OR PROPHYLAXES OF CLINICAL STATES FOR WHICH ADMINISTRATION OF 5-HT-LIKE RECEPTOR AGONIST, AND METHOD OF PREPARING THEREOF 1991
  • Alan Dunkan Robertson
  • Alan Piter Khill
  • Robert Charl'Z Glen
  • Grem Richard Martin
RU2160736C2
METHOD FOR PRODUCTION OF 3-ALKYLATED INDOLE AND (2-NITROPHENYL)-ACETALDEHYDE 1991
  • Robert Toms Dzhehkobs[Gb]
  • Dzherard Frehnsis Kostello[Gb]
  • Stefen Alan Bruk[Gb]
  • Piter Dzhon Kharrison[Gb]
RU2054417C1
PHYSICAL FOAM OF (R)-3-METHOXY-4-1-METHYL-5- 2-METHYL- 4,4,4-TRIFLUOROBUTYLCARBAMOYL) INDOL-3-YLMETHYL-N-(2- METHYLPHENYL-SULPHONYL)BENZAMIDE, PHARMACEUTICAL COMPOSITION HAVING PROPERTIES OF LEUCOTRIENE ANTAGONIST 1992
  • Murrej Vatson Katbert[Gb]
RU2095348C1
HALOGENATED ESTER, METHOD OF PREPARING THEREOF, AND METHOD OF PREPARING 3-(2-CHLORO-3,3,3-TRIFLUOROPROP-1- ENE-1-YL)-2,2-DIMETHYL CYCLOPROPANECARBOXYLIC ACID ALKYL ESTER 1995
  • Martin Charl'Z Bouden
RU2144528C1
N,N-DIMETHYL-2-(5-(2-OXO-1,3-OXAZOLIDINE-4-YL-METHYL)-1H-INDO- -LE-3-YL)-ETHYLAMINE, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR SOLVATE, METHOD OF ITS SYNTHESIS, DRUG USED AS AN AGONIST OF "5-HT-LIKE" RECEPTOR IN MAMMALS, METHOD OF DRUG AGENT PREPARING 1991
  • Alan Dunkan Robertson[Gb]
  • Alan Piter Khill[Gb]
  • Robert Cherl'Z Glen[Gb]
  • Grehm Richard Martin[Gb]
RU2110517C1
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF 1996
  • Bro Glorija Ehnn
RU2198878C2
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF 1996
  • Bro Glorija Ehnn
RU2182574C2
QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR 1997
  • Tomas Ehndrju Peter
  • Dzhonstoun Krehjg
  • Ehnnekehn Loran Fransua Andre
RU2196137C2
PROLINE DERIVATIVES SUITABLE AS HUMAN LEUKOCYTE ELASTASE INHIBITORS 1996
  • Peter Robert Bernshtejn
  • Kris Allan Vil
  • Ehlvin Peter Dehvis
RU2159249C2
PREPARATION OF HALOGENATED ALCOHOLS 1994
  • Martin Charl'Z Bouden
  • Majkl Drajzdejl Ternball
RU2129538C1

RU 2 167 875 C2

Authors

Rehjnikant Pehjtel

Dates

2001-05-27Published

1996-08-02Filed